Capstone Triton Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Capstone Triton Financial Group's ABBV Position: Q1 2026 in Review
Capstone Triton Financial Group sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 8,641 shares — an estimated $1.97M sold.
Capstone Triton Financial Group first reported a position in ABBV in Q4 2020 and held it in 20 quarters. The position peaked at $1.97M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Capstone Triton Financial Group reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Capstone Triton Financial Group sold 8,641 AbbVie shares in Q1 2026, an estimated $1.97M.
- Capstone Triton Financial Group first reported a position in AbbVie in Q4 2020 and held it in 20 quarters.
- Capstone Triton Financial Group's AbbVie position peaked at $1.97M in Q4 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Capstone Triton Financial Group's 13F filing for Q1 2026, filed 15 May 2026.